
Investigating Fraud At The Heart Of Alzheimer’s Research
Science Friday
Unraveling Alzheimer's Research Misconduct
This chapter investigates the development of the Alzheimer's drug semifilum by Cassava Sciences, uncovering issues of manipulated data and misconduct. It sheds light on the FDA's awareness of these problems, the impact of the amyloid hypothesis on research, and the prevalence of doctored images in scientific studies. The discussion reveals the consequences of confirmation bias and the risk it poses to the integrity of Alzheimer's research.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.